Literature DB >> 21849244

Prenatal cocaine exposure and small-for-gestational-age status: effects on growth at 6 years of age.

Seetha Shankaran1, Abhik Das, Charles R Bauer, Henrietta S Bada, Barry M Lester, Linda L Wright, Rosemary D Higgins, W Kenneth Poole.   

Abstract

OBJECTIVE: To evaluate the impact of prenatal cocaine exposure and small-for-gestational-age (SGA) status on childhood growth. STUDY
DESIGN: Cocaine exposure was defined by history or meconium metabolites. Hierarchical linear modeling was used to examine cocaine exposure and SGA status on growth, while controlling for exposure to other drugs and alcohol use.
RESULTS: At birth cocaine-exposed infants (n=364) had significantly lower growth parameters compared to non-exposed children (n=771). At 6 years, weight was similar between exposed and unexposed children. SGA infants continued to be growth impaired. There was a significant interaction between prenatal cocaine exposure and SGA status at 6 years. The negative effects of cocaine on weight and height were greater among non-SGA than SGA children (432 vs. 280 gm, and 0.7 and 0.5 cm, respectively) while negative effects of SGA status on weight and height were larger in non-cocaine exposed compared to the exposed children (2.3 kg vs.1.6 kg and 2.2 and 1.0 cm).
CONCLUSIONS: Children exposed to prenatal cocaine were similar in weight to non-exposed children at 6 years of age. Cocaine had an unexplained greater detrimental effect on non-SGA than SGA children. SGA status at birth has an independent detrimental effect on childhood growth.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849244      PMCID: PMC3183411          DOI: 10.1016/j.ntt.2011.04.003

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  26 in total

1.  Prediction of male adult stature using anthropometric data at birth: a nationwide population-based study.

Authors:  T Tuvemo; S Cnattingius; B Jonsson
Journal:  Pediatr Res       Date:  1999-11       Impact factor: 3.756

2.  Alcohol, tobacco and marijuana use among pregnant teenagers: 6-year follow-up of offspring growth effects.

Authors:  Marie D Cornelius; Lidush Goldschmidt; Nancy L Day; Cynthia Larkby
Journal:  Neurotoxicol Teratol       Date:  2002 Nov-Dec       Impact factor: 3.763

3.  Does maternal smoking during pregnancy cause childhood overweight?

Authors:  Marius Widerøe; Torstein Vik; Geir Jacobsen; Leiv S Bakketeig
Journal:  Paediatr Perinat Epidemiol       Date:  2003-04       Impact factor: 3.980

4.  Intrauterine growth of full-term infants: impact of prenatal cocaine exposure.

Authors:  E S Bandstra; C E Morrow; J C Anthony; S S Churchill; D C Chitwood; B W Steele; A Y Ofir; L Xue
Journal:  Pediatrics       Date:  2001-12       Impact factor: 7.124

5.  Gestational cocaine exposure and intrauterine growth: maternal lifestyle study.

Authors:  Henrietta S Bada; Abhik Das; Charles R Bauer; Seetha Shankaran; Barry Lester; Linda L Wright; Joel Verter; Vincent L Smeriglio; Loretta P Finnegan; Penelope L Maza
Journal:  Obstet Gynecol       Date:  2002-11       Impact factor: 7.661

6.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

7.  Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study.

Authors:  Chandice Y Covington; Beth Nordstrom-Klee; Joel Ager; Robert Sokol; Virginia Delaney-Black
Journal:  Neurotoxicol Teratol       Date:  2002 Jul-Aug       Impact factor: 3.763

8.  Association between patterns of maternal substance use and infant birth weight, length, and head circumference.

Authors:  Seetha Shankaran; Abhik Das; Charles R Bauer; Henrietta S Bada; Barry Lester; Linda L Wright; Vincent Smeriglio
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

9.  Early alteration of structural and functional brain development in premature infants born with intrauterine growth restriction.

Authors:  Cristina Borradori Tolsa; Slava Zimine; Simon K Warfield; Monica Freschi; Ana Sancho Rossignol; Francois Lazeyras; Sylviane Hanquinet; Mirjam Pfizenmaier; Petra S Huppi
Journal:  Pediatr Res       Date:  2004-05-05       Impact factor: 3.756

10.  Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood.

Authors:  Santosh K Bhargava; Harshpal Singh Sachdev; Caroline H D Fall; Clive Osmond; Ramakrishnan Lakshmy; David J P Barker; Sushant K Dey Biswas; Siddharth Ramji; Dorairaj Prabhakaran; Kolli Srinath Reddy
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

View more
  6 in total

1.  Neurobehavioral and Developmental Traiectories Associated with Level of Prenatal Cocaine Exposure.

Authors:  Claudia A Chiriboga; Louise Kuhn; Gail A Wasserman
Journal:  J Neurol Psychol       Date:  2014-11

2.  Prenatal psychobiological predictors of anxiety risk in preadolescent children.

Authors:  Elysia Poggi Davis; Curt A Sandman
Journal:  Psychoneuroendocrinology       Date:  2012-01-20       Impact factor: 4.905

Review 3.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

4.  Effects of prenatal cocaine exposure on adolescent development.

Authors:  Gale A Richardson; Lidush Goldschmidt; Cynthia Larkby; Nancy L Day
Journal:  Neurotoxicol Teratol       Date:  2015-03-14       Impact factor: 3.763

5.  Effects of prenatal cocaine exposure on child behavior and growth at 10 years of age.

Authors:  Gale A Richardson; Lidush Goldschmidt; Cynthia Larkby; Nancy L Day
Journal:  Neurotoxicol Teratol       Date:  2013-08-24       Impact factor: 3.763

6.  The Neonatal Research Network: History since 2003, future directions and challenges.

Authors:  Rosemary D Higgins; Seetha Shankaran
Journal:  Semin Perinatol       Date:  2016-06-29       Impact factor: 3.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.